what are the glp-1 medications List of approved and pending Part 1 of a 3-Part

Latest Clinical Trial Highlights (2026) Recent research continues evaluating: BPC-157's ability to rescue damaged endothelial tissue TB-500's impact on severe cardiac tissue remodeling Combination therapies utilizing both peptides for complete musculoskeletal tear models Long-term tissue remodeling versus acute wound closure Researchers continue monitoring these pathways to understand chronic tissue degeneration better

Lateral septal CNS circuits, renal tubular natriuresis, hepatic lipid flux regulation, and direct cardiac signaling each contribute to the clinical benefit profile in tissue-selective ways

Primary applications focus on skin rejuvenation and surface wound healing, distinct from BPC-157s deep tissue focus

Hatami E, Ghalishourani SS, Najafgholizadeh A, Pourmasoumi M, Hadi A, Clark CCT, Assaroudi M, Salehi-Sahlabadi A, Joukar F, Mansour-Ghanaei F